Clinical Trials Browser

Phase 1 × Gallbladder Neoplasms × 30 days × Clear all

NCT07594964 2026-05-19

To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors

Phase 1 Recruiting

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Cholangiocarcinoma